Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
This study has been completed.
Sponsor:
Amgen
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT00035594
First received: May 3, 2002
Last updated: May 7, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2004 |
| Primary Completion Date: | February 2004 (Final data collection date for primary outcome measure) |